Literature DB >> 3923492

Pain pathways in the primate.

W D Willis.   

Abstract

From the work reviewed here, it appears that the classical view that there is a sensory channel for pain sensation rather like sensory channels for other sensations seems plausible. However, pain has the property of producing more prominent motivational-affective behaviors than do other sensations (although there are certainly motivational-affective components of the responses to many sensory experiences, such as a verbal attack or the odor of a favorite perfume). It may be that certain nociceptive neurons, such as the STT cells that project to the medial thalamus that have total body receptive fields and many similar spinoreticular neurons, are concerned not so much with sensory events but rather with motivational-affective responses. Nevertheless, there are specific nociceptive afferent fibers, nociceptive spinothalamic tract cells with restricted receptive fields, nociceptive VPL thalamic and SI cortical neurons that presumably could play a crucial role in the sensory-discriminative aspects of pain (signalling, for example, stimulus intensity, location, duration, rate, and quality). Interestingly, many nociceptive neurons receive a convergent input from both sensitive mechanoreceptors and from nociceptors and so can be classified as "wide dynamic range" or multiconvergent neurons. It is not at all clear what the significance is of this kind of multimodal convergence. One possibility is that the weaker tactile input is treated as noise and largely ignored by higher processing centers in the brain. Another possibility is that WDR cells are switched in function by the action of descending pathways originating in the brain stem or cerebral cortex (cf., Gerhart et al., 1984; Yezierski et al., 1983). In any event, the solution of this problem is likely to be very important for the full understanding of the coding properties of nociceptive neurons, and this issue is reminiscent of the coding problem discussed by David Smith in this volume with respect to the gustatory system.

Entities:  

Mesh:

Year:  1985        PMID: 3923492

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  6 in total

Review 1.  [Studies on cerebral processing of pain using functional imaging : Somatosensory, emotional, cognitive, autonomic and motor aspects].

Authors:  M Valet; T Sprenger; T R Tölle
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

2.  An Innovative High-Tech Acupuncture Product: SXDZ-100 Nerve Muscle Stimulator, Its Theoretical Basis, Design, and Application.

Authors:  Xinyan Gao; Peijing Rong; Liang Li; Wei He; Hui Ben; Bing Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-09       Impact factor: 2.629

3.  From nociception to pain perception, possible implications of astrocytes.

Authors:  Frida Higinio-Rodríguez; Angélica Rivera-Villaseñor; Isnarhazni Calero-Vargas; Mónica López-Hidalgo
Journal:  Front Cell Neurosci       Date:  2022-09-07       Impact factor: 6.147

4.  Delta opioid receptor activation modulates affective pain and modality-specific pain hypersensitivity associated with chronic neuropathic pain.

Authors:  Catherine M Cahill; Sarah V Holdridge; Shiwei Steve Liu; Lihua Xue; Claire Magnussen; Edmund Ong; Patrick Grenier; Anne Sutherland; Mary C Olmstead
Journal:  J Neurosci Res       Date:  2020-07-05       Impact factor: 4.164

5.  Pain and itch processing by subpopulations of molecularly diverse spinal and trigeminal projection neurons.

Authors:  Racheli Wercberger; Joao M Braz; Jarret A Weinrich; Allan I Basbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-13       Impact factor: 11.205

6.  fNIRS brain measures of ongoing nociception during surgical incisions under anesthesia.

Authors:  Stephen Green; Keerthana Deepti Karunakaran; Robert Labadie; Barry Kussman; Arielle Mizrahi-Arnaud; Andrea Gomez Morad; Delany Berry; David Zurakowski; Lyle Micheli; Ke Peng; David Borsook
Journal:  Neurophotonics       Date:  2022-01-27       Impact factor: 4.212

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.